Table of Contents Author Guidelines Submit a Manuscript
Journal of Drug Delivery
Volume 2016 (2016), Article ID 8046739, 12 pages
http://dx.doi.org/10.1155/2016/8046739
Research Article

Stabilized Polymer Micelles for the Development of IT-147, an Epothilone D Drug-Loaded Formulation

Intezyne Technologies, 3720 Spectrum Blvd. Ste. 104, Tampa, FL, USA

Received 3 August 2016; Revised 18 October 2016; Accepted 2 November 2016

Academic Editor: Jia You Fang

Copyright © 2016 Adam Carie et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Reichenbach and G. Höfle, “Biologically active secondary metabolites from myxobacteria,” Biotechnology Advances, vol. 11, no. 2, pp. 219–277, 1993. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Hofle, “Epothilone A and B—novel 16-membered macrolides with cytotoxic activity: isolation, crystal structure, and conformation in solution,” Angewandte Chemie, vol. 35, pp. 1567–1569, 1996. View at Google Scholar
  3. K. Gerth, N. Bedorf, G. Höfle, H. Irschik, and H. Reichenbach, “Epothilons A and B: antifungal and cytotoxic compounds from Sorangium cellulosum (Myxobacteria) production, physico-chemical and biological properties,” The Journal of Antibiotics, vol. 49, no. 6, pp. 560–563, 1996. View at Publisher · View at Google Scholar · View at Scopus
  4. D. M. Bollag, P. A. McQueney, J. Zhu et al., “Epothilones, a new class of microtubule-stabilizing agents with a taxol- like mechanism of action,” Cancer Research, vol. 55, no. 11, pp. 2325–2333, 1995. View at Google Scholar · View at Scopus
  5. R. J. Kowalski, P. Giannakakou, and E. Hamel, “Activities of the microtubule-stabilizing agents epothilones A and B with purified tubulin and in cells resistant to paclitaxel (Taxol®),” The Journal of Biological Chemistry, vol. 272, no. 4, pp. 2534–2541, 1997. View at Publisher · View at Google Scholar · View at Scopus
  6. K. C. Nicolaou, N. Winssinger, J. Pastor et al., “Synthesis of epothilones A and B in solid and solution phase,” Nature, vol. 387, no. 6630, pp. 268–272, 1997. View at Publisher · View at Google Scholar · View at Scopus
  7. F. Y. F. Lee, R. Borzilleri, C. R. Fairchild et al., “BMS-247550: a novel epothilone analog with a mode of action similar to paclitaxel but possessing superior antitumor efficacy,” Clinical Cancer Research, vol. 7, no. 5, pp. 1429–1437, 2001. View at Google Scholar · View at Scopus
  8. T.-C. Chou, H. Dong, A. Rivkin et al., “Design and total synthesis of a superior family of epothilone analogues, which eliminate xenograft tumors to a nonrelapsable state,” Angewandte Chemie, vol. 42, no. 39, pp. 4761–4767, 2003. View at Google Scholar · View at Scopus
  9. S. Goodin, M. P. Kane, and E. H. Rubin, “Epothilones: mechanism of action and biologic activity,” Journal of Clinical Oncology, vol. 22, no. 10, pp. 2015–2025, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. T. O'Reilly, P. M. J. McSheehy, F. Wenger et al., “Patupilone (epothilone B, EPO906) inhibits growth and metastasis of experimental prostate tumors in vivo,” Prostate, vol. 65, no. 3, pp. 231–240, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Fumoleau, B. Coudert, N. Isambert, and E. Ferrant, “Novel tubulin-targeting agents: anticancer activity and pharmacologic profile of epothilones and related analogues,” Annals of Oncology, vol. 18, supplement 5, pp. v9–v15, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. D.-S. Su, A. Balog, D. Meng et al., “Structure-activity relationship of the epothilones and the first in vivo comparison with paclitaxel,” Angewandte Chemie, vol. 36, no. 19, pp. 2093–2096, 1997. View at Publisher · View at Google Scholar
  13. T.-C. Chou, X.-G. Zhang, A. Balog et al., “Desoxyepothilone B: an efficacious microtubule-targeted antitumor agent with a promising in vivo profile relative to epothilone B,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 16, pp. 9642–9647, 1998. View at Publisher · View at Google Scholar · View at Scopus
  14. T.-C. Chou, X.-G. Zhang, C. R. Harris et al., “Desoxyepothilone B is curative against human tumor xenografts that are refractory to paclitaxel,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 26, pp. 15798–15802, 1998. View at Publisher · View at Google Scholar · View at Scopus
  15. W. Blum, R. Aichholz, P. Ramstein et al., “In vivo metabolism of epothilone B in tumor-bearing nude mice: identification of three new epothilone B metabolites by capillary high-pressure liquid chromatography/mass spectrometry/tandem mass spectrometry,” Rapid Communications in Mass Spectrometry, vol. 15, no. 1, pp. 41–49, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. T.-C. Chou, O. A. O'Connor, W. P. Tong et al., “The synthesis, discovery, and development of a highly promising class of microtubule stabilization agents: curative effects of desoxyepothilones B and F against human tumor xenografts in nude mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 14, pp. 8113–8118, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. J. M. G. Larkin and S. B. Kaye, “Potential clinical applications of epothilones: a review of phase II studies,” Annals of Oncology, vol. 18, no. 5, pp. v28–v34, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. S. W. B. Overmoyer, P. A. Kaufman, T. Doyle et al., “Phase II trial of KOS-862 (epothilone D) in anthracycline and taxane pretreated metastatic breast cancer,” Journal of Clinical Oncology, vol. 23, article 778, 2005. View at Google Scholar
  19. T. L. L. Yee, M. Villalona-Calero, N. Rizvi et al., “A phase II study of KOS-862 (epothilone D) as second-line therapy in non-small cell lung cancer,” Journal of Clinical Oncology, vol. 23, p. 7127, 2005. View at Google Scholar
  20. D. R. Feldman, G. V. Kondagunta, M. S. Ginsberg et al., “Phase II Trial of ixabepilone in patients with cisplatin-refractory germ cell tumors,” Investigational New Drugs, vol. 25, no. 5, pp. 487–490, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. S. McMeekin, D. Dizon, J. Barter et al., “Phase III randomized trial of second-line ixabepilone versus paclitaxel or doxorubicin in women with advanced endometrial cancer,” Gynecologic Oncology, vol. 138, no. 1, pp. 18–23, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. H. S. Rugo, W. T. Barry, A. Moreno-Aspitia et al., “Randomized phase III trial of paclitaxel once per week compared with nanoparticle albumin-bound nab-paclitaxel once per week or ixabepilone with bevacizumab as first-line chemotherapy for locally recurrent or metastatic breast cancer: CALGB 40502/NCCTG N063H (Alliance),” Journal of Clinical Oncology, vol. 33, no. 21, pp. 2361–2369, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. V. J. Venditto and F. C. Szoka Jr., “Cancer nanomedicines: so many papers and so few drugs!,” Advanced Drug Delivery Reviews, vol. 65, no. 1, pp. 80–88, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Stylianopoulos and R. K. Jain, “Design considerations for nanotherapeutics in oncology,” Nanomedicine: Nanotechnology, Biology, and Medicine, vol. 11, no. 8, pp. 1893–1907, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. X. Zhang, Y. Lin, and R. J. Gillies, “Tumor pH and its measurement,” Journal of Nuclear Medicine, vol. 51, no. 8, pp. 1167–1170, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. J. A. Mindell, “Lysosomal acidification mechanisms,” Annual Review of Physiology, vol. 74, pp. 69–86, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Wang, S. Li, T. Luo, C. Wang, and J. Zhao, “Disulfide linkage: a potent strategy in tumor-targeting drug discovery,” Current Medicinal Chemistry, vol. 19, no. 18, pp. 2976–2983, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. (K.T. Sill, FL, US), Vojkovsky, Tomas (Palm Beach Gardens, FL, US), Carie, Adam (Ruskin, FL, US), Block copolymers for stable micelles, in, Intezyne Technologies, Inc. (Tampa, FL, US), United States, 2015.
  29. T. L. C. Costich, A. Semple, J. E. Sullivan et al., “IT-143, a polymer micelle nanoparticle, widens therapeutic window of daunorubicin,” Pharmaceutical Nanotechnology, vol. 4, no. 1, pp. 3–15, 2016. View at Publisher · View at Google Scholar
  30. L. Yuan, Y. Fu, D. Zhang et al., “Use of a carboxylesterase inhibitor of phenylmethanesulfonyl fluoride to stabilize epothilone D in rat plasma for a validated UHPLC-MS/MS assay,” Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 969, pp. 60–68, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. K. C. Nicolaou, P. K. Sasmal, G. Rassias et al., “Design, synthesis, and biological properties of highly potent epothilone B analogues,” Angewandte Chemie, vol. 42, no. 30, pp. 3515–3520, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. G. H. K.-H. Altman, R. Muller, J. Mulzer, and K. Prantz, The Epothilones: An Outstanding Family of Anti-Tumor Agents, Springer, New York, NY, USA, 2009.
  33. I. F. Tannock and D. Rotin, “Acid pH in tumors and its potential for therapeutic exploitation,” Cancer Research, vol. 49, no. 16, pp. 4373–4384, 1989. View at Google Scholar · View at Scopus
  34. D. B. Leeper, K. Engin, A. J. Thistlethwaite et al., “Human tumor extracellular pH as a function of blood glucose concentration,” International Journal of Radiation Oncology, Biology, Physics, vol. 28, no. 4, pp. 935–943, 1994. View at Publisher · View at Google Scholar · View at Scopus
  35. K. Engin, D. B. Leeper, J. R. Cater, A. J. Thistlethwaite, L. Tupchong, and J. D. Mcfarlane, “Extracellular pH distribution in human tumours,” International Journal of Hyperthermia, vol. 11, no. 2, pp. 211–216, 1995. View at Publisher · View at Google Scholar · View at Scopus
  36. A. S. E. Ojugo, P. M. J. McSheehy, D. J. O. McIntyre et al., “Measurement of the extracellular pH of solid tumours in mice by magnetic resonance spectroscopy: a comparison of exogenous 19F and 31P probes,” NMR in Biomedicine, vol. 12, no. 8, pp. 495–504, 1999. View at Google Scholar · View at Scopus
  37. R. van Sluis, Z. M. Bhujwalla, N. Raghunand et al., “In vivo imaging of extracellular pH using 1H MRSI,” Magnetic Resonance in Medicine, vol. 41, no. 4, pp. 743–750, 1999. View at Publisher · View at Google Scholar · View at Scopus